Interferons and cancer therapy
- 1 November 1983
- journal article
- review article
- Published by Wiley in The Journal of Pathology
- Vol. 141 (3), 287-295
- https://doi.org/10.1002/path.1711410308
Abstract
A variety of human interferons, alpha, beta and gamma are now recognised. Three types of alpha-interferon have been submitted to clinical assessment. Overall, the results have been disappointing. Attention is now directed towards their use in combination with conventional cytotoxic agents.Keywords
This publication has 14 references indexed in Scilit:
- Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's SarcomaNew England Journal of Medicine, 1983
- Neurological effects of recombinant human interferon.BMJ, 1983
- The present status of clinical studies with interferons in cancer in BritainPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1982
- Interferon Therapy in Juvenile Laryngeal PapillomatosisJAMA Otolaryngology–Head & Neck Surgery, 1981
- Toxicity of interferon.BMJ, 1981
- Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant LymphomaAnnals of Internal Medicine, 1980
- INITIAL EVALUATION OF HUMAN LYMPHOBLASTOID INTERFERON IN PATIENTS WITH ADVANCED MALIGNANT DISEASEThe Lancet, 1980
- Interferon: An anti-cancer agent?Cancer Treatment Reviews, 1979
- INTERFERON THERAPY IN MYELOMATOSISThe Lancet, 1979
- Mechanism of the Antitumour Effect of Interferon in MiceNature, 1972